DM, S. (2026). Active treatment in high-risk, early-stage CLL or SLL. Clinical advances in hematology & oncology : H&O, 24(4), 259.
Chicago Style (17th ed.) CitationDM, Stephens. "Active Treatment in High-risk, Early-stage CLL or SLL." Clinical Advances in Hematology & Oncology : H&O 24, no. 4 (2026): 259.
MLA (9th ed.) CitationDM, Stephens. "Active Treatment in High-risk, Early-stage CLL or SLL." Clinical Advances in Hematology & Oncology : H&O, vol. 24, no. 4, 2026, p. 259.
Warning: These citations may not always be 100% accurate.